| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000006465 |
| Receipt No. | R000007672 |
| Official scientific title of the study | Comparison and evaluation of different effects of three alpha-Glucosidase inhibitors on lowering blood sugar and body weight in Japanese obese patients with type 2 diabetes |
| Date of disclosure of the study information | 2011/10/04 |
| Last modified on | 2018/06/27 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Comparison and evaluation of different effects of three alpha-Glucosidase inhibitors on lowering blood sugar and body weight in Japanese obese patients with type 2 diabetes | |
| Title of the study (Brief title) | Nippon Medical School Group:Clinical Usefulness Research of alpha-glucosidase inhibitor Effect on Type 2 Diabetes Mellitus with Obesity (N-CURE Study) | |
| Region |
|
|
| Condition | ||
| Condition | Type 2 Diabetes Mellitus | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | In this study, we compare Miglitol, Acarbose, and Voglibose, with a control group comprised of patients who received no alpha-GI therapy, on their effects on glycemic and weight control and other clinical benefits in Japanese obese patients with type 2 diabetes. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | HbA1c,1.5-AG,Body Weight,BMI |
| Key secondary outcomes | FPG,Serum Insulin,HOMA-IR,Adiponectin,Leptin,
Questionnaires(digestive symptoms,appetite,drug compliance) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 4 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Miglitol 150mg/day 12weeks | |
| Interventions/Control_2 | Voglibose 0.9mg/day 12weeks | |
| Interventions/Control_3 | Acarbose 300mg/day 12weeks | |
| Interventions/Control_4 | Non-alpha-GI-treated 12weeks | |
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Japanese patients of both sexes, age 40 or older who were under the care of one of the study centers and who were obese patients with type 2 diabetes with an HbA1c of 6.4% to 8.4% (NGSP) and a body mass index (BMI) of 25 kg/m2 or above. | |||
| Key exclusion criteria | Patients on insulin therapy and patients with a serious hepatic, renal, or cardiac disease | |||
| Target sample size | 80 | |||
| Research contact person | |
| Name of lead principal investigator | Shinichi Oikawa |
| Organization | Nippon Medical School |
| Division name | Division of Endocrinology and Metabolism, Department of Medicine |
| Address | 1-1-5, Sendagi,Bunkyo-ku,Tokyo |
| TEL | 03-3822-2131 |
| shinichi@nms.ac.jp | |
| Public contact | |
| Name of contact person | Shinichi Oikawa |
| Organization | Nippon Medical School |
| Division name | Division of Endocrinology and Metabolism, Department of Medicine |
| Address | 1-1-5, Sendagi,Bunkyo-ku,Tokyo |
| TEL | 03-3822-2131 |
| Homepage URL | |
| shinichi@nms.ac.jp | |
| Sponsor | |
| Institute | Nippon Medical School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | SANWA KAGAKU KENKYUSHO CO.,LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 日本医科大学附属病院(東京都)、国民健康保険八丈町立八丈病院(東京都)、自治医科大学附属さいたま医療センター(埼玉県)、乙成内科医院(福岡県)、柏市立柏病院(千葉県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000007672 |